High TRIP6 mRNA expression was observed in premenopausal (p = 0.033) and progesterone receptor positive (p = 0.020) breast cancer in the adjuvant cohort of breast cancer patients but not in the neoadjuvant cohort (p = 0.50 and p = 0.77, respectively) (Table 5). This evidence concerns the gene TRIP6 and breast cancer.